Gynopedia needs your support! Please consider contributing content, translating a page, or making a donation today. With your support, we can sustain and expand the website. Gynopedia has no corporate sponsors or advertisers. Your support is crucial and deeply appreciated.
All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found one translation.
Name | Current message text |
---|---|
h English (en) | Regarding HPV, India has been slow to begin offer vaccination programs. The first national program was launched in New Dehli in 2016.<ref>[http://www.ibtimes.co.in/delhi-launches-countrys-first-hpv-vaccination-programme-fight-cervical-cancer-668834#wflESAjVaLqv6qM3.97 Delhi launches country's first HPV vaccination programme to fight cervical cancer]</ref> Regarding PrEP, according to PrEPWatch: "India is host to a PrEP demonstration project among female sex workers in Durbar Mahila Samanwaya Committee, a brothel-based project in Sonagachi, and the Ashodaya Samithi project for street-based sex workers based in Mysore. It is scheduled to run from December 2015 to early 2017. Truvada is registered for treatment. It is not registered for prevention. There is no national PrEP policy or guidance at present. However, the ongoing demonstration project may be used to inform such policy."<ref>[http://www.prepwatch.org/india/ PrEpWatch: India]</ref> |